PD Dr. Bastian Keck



Organisationseinheit


Medizinische Fakultät


Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 5 Go to next page Go to last page

Erben, P., Sikic, D., Wirtz, R.M., Martini, T., Weis, C.-A., Breyer, J.,... Bolenz, C. (2019). Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladder. Virchows Archiv, 474(2), 209–217. https://dx.doi.org/10.1007/s00428-018-2496-9
Sikic, D., Wirtz, R.M., Wach, S., Dyrskjot, L., Erben, P., Bolenz, C.,... Keck, B. (2019). Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts. Translational Oncology, 12(4), 661-668. https://dx.doi.org/10.1016/j.tranon.2019.01.005
Ihrig, A., Renner, T., Muck, T., Maatz, P., Borkowetz, A., Keck, B.,... Huber, J. (2019). Online support groups offer low-threshold backing for family and friends of patients with prostate cancer. European Journal of Cancer Care, 28(2). https://dx.doi.org/10.1111/ecc.12982
Eckstein, M., Erben, P., Kriegmair, M.C., Worst, T.S., Weiss, C.-A., Wirtz, R.M.,... Erlmeier, F. (2019). Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab. European journal of cancer, 106, 234-243. https://dx.doi.org/10.1016/j.ejca.2018.11.007
Eckstein, M., Wirtz, R., Pfannstil, C., Wach, S., Stoehr, R., Breyer, J.,... Erben, P. (2018). A multicenter comparison of PD-L1 protein and mRNA expression in urothelial bladder cancer by immunohistochemistry and RT-qPCR (Checkpoint-Typer(C)): A round robin test by the BRIDGE-Consortium Germany. (pp. 81-81).
Eckstein, M., Wirtz, R.M., Pfannstil, C., Wach, S., Stoehr, R., Breyer, J.,... Erben, P. (2018). A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy. Oncotarget, 9(19), 15001-15014. https://dx.doi.org/10.18632/oncotarget.24531
Sikic, D., Wirtz, R., Wach, S., Dyrskjot, L., Erben, P., Bolenz, C.,... Keck, B. (2018). Analysis of androgen receptor mRNA expression in urothelial carcinoma of the bladder. (pp. 70-70).
Wach, S., Weigelt, K., Michalke, B., Lieb, V., Stoehr, R., Keck, B.,... Chaudhri, A. (2018). Diagnostic potential of major and trace elements in the serum of bladder cancer patients. Journal of Trace Elements in Medicine and Biology, 46, 150-155. https://dx.doi.org/10.1016/j.jtemb.2017.12.010
Huber, J., Muck, T., Maatz, P., Keck, B., Enders, P., Maatouk, I., & Ihrig, A. (2018). Face-to-face vs. online peer support groups for prostate cancer: A cross-sectional comparison study. Journal of Cancer Survivorship, 12(1), 1-9. https://dx.doi.org/10.1007/s11764-017-0633-0
Van Kessel, K.E.M., Van Der Keur, K.A., Dyrskjot, L., Algaba, F., Welvaart, N.Y.C., Beukers, W.,... Zwarthoff, E.C. (2018). Molecular Markers Increase Precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk Groups. Clinical Cancer Research, 24(7), 1586-1593. https://dx.doi.org/10.1158/1078-0432.CCR-17-2719

Zuletzt aktualisiert 2018-03-04 um 02:00